Announcements Trials
Browse Landscape

Phase

Phase 4 2Phase NA 1Phase 3 1Phase 2 1

Status

Completed 18Terminated 9Recruiting 9Unknown 7Not yet recruiting 5Active not recruiting 4Withdrawn 2

Sponsor Class

OTHER 5

Study Type

Interventional 5

Sponsor

Cancer Type

Gynecologic 3Breast 2Other 1

Conditions

Endometrial Neoplasms 2Endometrial Hyperplasia 2Turcot syndrome 1Overweight 1Obesity 1Neoplasms 1Carcinoma, Endometrioid 1Breast Neoplasms 1Breast Cancer Patients Treated With T-DXd 1

Interventions

Carboplatin 126Cisplatin 125Drug Therapy 103Bevacizumab 98Oxaliplatin 97Capecitabine 97Radiotherapy 94Gemcitabine 87Paclitaxel 85tislelizumab 84Cyclophosphamide 82pembrolizumab 77Specimen Handling 77toripalimab 69Injections 63Fluorouracil 62Magnetic Resonance Spectroscopy 61sintilimab 57anlotinib 53130-nm albumin-bound paclitaxel 51Surgical Procedures, Operative 50Docetaxel 49fludarabine 46Pemetrexed 45venetoclax 42Standard of Care 42Leucovorin 42Irinotecan 41lenvatinib 40Biopsy 39

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Not yet recruiting × Interventional × Megestrol Acetate × Clear all
NCT07462663 2026-05-13

SHAPE-ENDO

Hospital Universitari de Bellvitge

Phase 4 Not yet recruiting
82 enrolled
GynecologicOther

Endometrial Hyperplasia, Neoplasms, Obesity, Endometrial Neoplasms, Overweight

NCT07543536 2026-04-22

MEGA-TACT-BC3

Sun Yat-sen University

Phase 3 Not yet recruiting
132 enrolled
Breast

Breast Neoplasms

NCT07436793 2026-02-27

Progestins for the Treatment of Endometrial Cancer or Precancers of the Uterus Before Surgery, The Pro-Window Trial

New Mexico Cancer Research Alliance

Phase 2 Not yet recruiting
140 enrolled
Gynecologic

Endometrial Hyperplasia

NCT07254416 2025-11-28

A Study on Nausea and Vomiting Caused by T-DXd in Breast Cancer Patients

Tianjin Medical University Cancer Institute and Hospital

Phase 4 Not yet recruiting
120 enrolled
Breast

Breast Cancer Patients Treated With T-DXd

NCT06549855 2024-08-12

PD-1 Inhibitor Combined With Progesterone Treatment in FST for Patients With MMRd Endometrial Cancer

Peking University People's Hospital

Phase NA Not yet recruiting
10 enrolled
Gynecologic

Turcot syndrome, Endometrial Neoplasms, Carcinoma, Endometrioid

Data powered by HemOnc (CC BY 4.0) Colophon âš¡